Connect with us

Business

History Does Not Repeat Itself, But It Does Rhyme – Lessons the Marijuana Industry Can Learn from the Alcohol Industry

Published

on

American history has not been kind to cannabis but despite all odds, the psychoactive herb has gone mainstream in American society even though it is still federally illegal. Cannabis has gone far from just being a cultural mainstay for movies and music to us seeing cannabis-based products on the shelves of makeup counters, grocery stores and wellness shops.

It is now a common sight for celebrities and chefs to host cannabis-infused dinners for their friends and selected fans. Even Martha Stewart, a local celebrity recognized for proper and prim living, is an active cannabis aficionado who now has her line of CBD-based products.

In the same vein alcohol, moved from the speakeasy to mainstream, and cannabis is taking a similar part and is building for itself a new space in modern culture. This is not so surprising considering there are many similarities between how alcohol was able to grow and re-emerge into the mainstream since the Prohibition years and the rise of cannabis use in the modern era.

Alcohol beverages have now become an integral part of modern culture and have been embraced into every aspect of life. According to the latest data from Federal Health Statistics, the average American drinks roughly 1.35 drinks per day, 9.5 drinks per week and 494 drinks per year that contain some form of alcohol.

Similar to alcohol, cannabis has walked through its distinct journey from being a lazy stoner habit to being integrated into every aspect of life both recreationally and medically. With cannabis and hemp-infused beverages now starting to take off, and in some cases ship across state lines, the beverage industry may be a good historical comparision. How does the cannabis industry the wine boom of the 1980s?

The factors that influenced alcohol’s rocky transition to the mainstream are complex and vast. However, when evaluated as an intermediary to cannabis normalization, there are three primary aspects the cannabis industry should focus on if it wants to cement itself in the mainstream. The three focus aspect include;

  • Offering a wide format variety
  • Encouraging more diverse usage occasions and
  • Specifying users’ expectations for a responsible experience.

Offering A Wide Format Variety

For cannabis to be accessible, the industry must explore the essence of options ans variety in boosting the normalization and appreciation of alcohol. For instance, what we have in the market today is a long list of spirit offerings ranging from high-end liquors to cheap, blended spirits. There’s also the option of unaged rums to decades-aged whiskies, flavorful gins to flavorless vodkas.

Today, consumers have the luxury of a wide variety of spirits in all kinds of groups at different price points. This ensures that the product suits every desire and pocket out there and this can be applied to cannabis. The criminalization and prohibition of cannabis made it difficult for innovative and inventive options to pop off. And in a lot of ways have alienated cannabis from potential users. But that narrative is rapidly evolving. For instance, there’s now a massive interest in vapes and concentrates.

As far back as 2018, concentrates have been rising through the chart. According to data released by BDSA, concentrates, in terms of sales expansion has surpassed flower since 2018. Now, cannabis beverages are beginning to have the spotlight as companies continue to understand how to improve production. More importantly, consumers are also starting to discover what joy it is to have cannabis drinks with zero hangovers.

Encouraging More Diverse Usage Occasions

Apart from formats, cannabis can also provide a wide variety of uses ans functions across different occasions all day. A unique ability the alcohol industry doesn’t have.

Even though alcohol has been able to position itself on multiple occasions, it is still very restricted. Alcohol is generally acceptable at social gatherings, mostly at night. Day/solo drinking is socially frowned upon. At a fundamental level, the function of alcohol is the same. A shot/glass/mug of your choice of alcohol will basically make you feel the same way.

But that’s not the case with cannabis. Cannabis use extends is quite deeper than the surface buzz of recreational cannabis use. People feel the impact of cannabis strains differently; its use is social and more individual. The continuously evolving innovations will only assist users in further redefining and defining their connections with cannabis

Also about how alcohol consumption norms developed with emerging participants coming up with modern ways to drink alcohol, the culture and lifestyle of cannabis are evolving. Rather than just rolling up a joint to get high, or managing a persisting health condition, amazing opportunities now present themselves for cannabis users. Users can now experience cannabis in unique ways such as to influence their moods and feeling.

Specifying Users’ Expectations For A Responsible Experience

Lastly, introducing newbies to have a peak cannabis experience largely depends on the authenticity of the product and entry-point education. The need to establish a predictable and consistent dosing standard then becomes highly necessary.

Again, let’s have a look at alcohol; the serving is defined. This is by careful and conscious design; for example, a cocktail, a glass of wine, and a beer all have the same alcohol content. This gives users an idea of what they taking and how to act around a type of alcohol and manage their experience. But, cannabis still has a long way to go as dosing standards have not been established.

Hence, the cannabis industry must seek to actively establish a dosing standard to alleviate the fears of cannabis effects. A common phrase in the industry is “everyone has an edible story” due to dosage uncertainties, especially for newbies. The industry must work together to ensure that this is left in the past.

Conclusion

As the chances for federal cannabis legalization continue to grow, the future of cannabis mustn’t be viewed through the lens of legacy or traditional consumers. Rather, the future of cannabis should be seen through the lens of individuals looking to improve their cannabis experience and enjoy life.

The cannabis culture has grown to be massive and there’s a place for everyone and anyone. Public acceptability is at a high-time high and the future promises more for every cannabis user.

Source: https://cannabis.net/blog/opinion/history-does-not-repeat-itself-but-it-does-rhyme-lessons-the-marijuana-industry-can-learn-from.283017

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News